Primate Somatic Cell Reprogramming via Defined Transcription Factors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating pluripotent cells from somatic cells are inefficient and often require embryonic tissues, leading to tissue rejection issues and the need for a more direct and efficient method to reprogram primate somatic cells.
Innovation Solution
The method involves exposing primate somatic cells to potency-determining factors such as Oct-4, Sox2, and Nanog, introduced through a vector, under specific conditions to reprogram the cells into a pluripotent state, achieving a higher potency level than the original somatic cells and maintaining genetic identity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods for generating pluripotent cells from somatic cells are used, then pluripotent cells can be obtained, but the process is inefficient and requires embryonic tissues leading to tissue rejection issues
Solution Approach 1:
The patent changes the parameters of the reprogramming process by using a defined set of transcription factors (Oct4, Sox2, Klf4, c-Myc) introduced via lentiviral vectors, transforming the reprogramming method from an inefficient process requiring embryonic tissues to a more efficient and reliable process using only somatic cells and defined molecular factors
Solution Approach 2:
The patent extracts and eliminates the requirement for embryonic tissues from the reprogramming process, achieving pluripotent cell generation from somatic cells alone through the introduction of specific transcription factors, thereby removing the source of tissue rejection issues
2Reliability
If a direct method to reprogram somatic cells is developed, then tissue rejection issues are avoided, but the reprogramming process becomes more complex
Solution Approach 1:
The patent uses lentiviral vectors as intermediaries to deliver the transcription factors (Oct4, Sox2, Klf4, c-Myc) into somatic cells, simplifying the reprogramming process while achieving reliable tissue-compatible pluripotent cell generation without direct manipulation of embryonic tissues
Solution Approach 2:
The patent develops a universal reprogramming method using a standardized set of transcription factors that can be applied to various somatic cell types to generate pluripotent cells with consistent tissue compatibility, making the process broadly applicable rather than cell-type specific
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.